COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc Announces ECDC Report Shows Rising HAIs and Antibiotic Use
ECDC report reveals rise in antibiotic-resistant HAIs, emphasizing Ondine Biomedical's light-activated antimicrobial technology. The technology offers a solution to combat antimicrobial resistance by killing all types of pathogens without causing resistance -
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
Sanofi and Novavax sign co-exclusive licensing agreement to co-commercialize COVID-19 vaccine & develop flu-COVID-19 combo vaccines. Agreement enhances patient access & protection. Details in press release -
